Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria
Open accessPublished version of a preprint
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The cell envelope of Mycobacterium tuberculosis , the bacterium that causes the disease tuberculosis, is a complex structure composed of abundant lipids and glycolipids, including the signature lipid of these bacteria, mycolic acids. In this study, we identified two new components of the transport machinery that constructs this complex cell wall. These two accessory proteins are in a complex with the MmpL3 transporter. One of these proteins, TtfA, is required for mycolic acid transport and cell viability, whereas the other stabilizes the MmpL3 complex. These studies identify two new components of the essential cell envelope biosynthetic machinery in mycobacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG 1 MmpL3 and MSMEG_0736 form a complex. (A) Silver-stained SDS-PAGE gel of elutions from GFP-Trap purifications using detergent solubilized membranes from M. smegmatis expressing MSMEG_0736-msfGFP (MGM6425) or MmpL3-msfGFP (MSMEG_0250 [MGM6464]). See Table 1 for protein identifications. (B) Silver-stained SDS-PAGE gel of the first elution from a GFP-Trap purification using detergent solubilized membranes from M. smegmatis expressing MSMEG_0736-msfGFP. The band corresponding to the molecular weight of MmpL3, indicated with an asterisk, was excised and subjected to mass spectrometry analysis and identified as MmpL3 (see Materials and Methods and Table S2 in the supplemental material).](https://figures.cochat.ai/paper-figures/9881fbcb65314c979bfa34c23c649eb8/two-accessory-proteins-govern-mmpl3-mycolic-acid-transport-in-mycobacteria-figure-1.jpg)
![FIG 2 MsTtfA/MtbTtfA is required for mycobacterial growth and cell elongation. (A) M. smegmatis strains with deletion of chromosomal ttfA and carrying a copy of ttfA at the attB phage integration site were subjected to marker exchange with attB integrating vectors. Δttfa attB::ttfA strep (MGM6414) strains transformed with pMV306kan (vector), pAJF792 (encoding MsTtfA), or pAJF793 (MtbTtfA) are shown on kanamycin agar. (B) Ten-fold dilutions of M. smegmatis carrying ATc-inducible CRISPRi nontargeting control (NT [MGM6418]) or ttfA (MGM6419) on agar media with and without ATc. (C) Growth curves of nontargeting (MGM6418, blue) and ttfA-targeting (MGM6419, red) CRISPRi M. smegmatis strains grown under uninduced (solid, closed circles) and ATc-induced (dashed, empty circles) conditions. (D) Growth curves of nontargeting (MGM6715, blue) or three distinct M. tuberculosis ttfA-targeting CRISPRi M. tuberculosis strains (MGM6675, red; MGM6677, green; MGM6679, purple) grown under uninduced (solid, closed circles) and ATc-induced (dashed, empty circles) conditions. (E) Fluorescence microscopy of an M. smegmatis ttfA-targeting CRISPRi strain marked with MalF(1,2)-mCitrine (MGM6433) 15 h post-CRISPRi induction with ATc (top, −TtfA) or, an uninduced control at 15 h (+TtfA, bottom). YFP (left) and DIC (right) images shown. Exposure times for YFP, 250 ms, 40% LED. (F) Loss of TtfA leads to short cells. Cell lengths of nontargeting (MGM6418, triangles) and TtfA-targeting (MGM6419, circles) CRISPRi strains induced for 12 h. Representative DIC/FM 4-64 images used for quantitation shown above the graph. Error bars are standard deviation and ** indicates P < 0.001.](https://figures.cochat.ai/paper-figures/1718de5a3e3b4aaa91ec4868afc086cd/two-accessory-proteins-govern-mmpl3-mycolic-acid-transport-in-mycobacteria-figure-2.jpg)

![FIG 4 TtfA and MmpL3 form a complex in vivo via the essential region of TtfA and independently of TMM synthesis. (A) DDM-solubilized M. smegmatis lysates (left) and GFP-Trap eluates (right) of msfGFP-expressing control (MGM6828) and TtfA-msfGFP (MGM6815) both coexpressing MmpL3-mCherry and probed with anti-RFP (top) and anti-GFP (bottom). (B) The essential region of MsTtfA is necessary and sufficient for MmpL3 interaction. DDM-solubilized lysates (top) and GFP-Trap eluates (bottom) of msfGFP control (MGM6828), full-length TtfA-msfGFP (1-278 [MGM6829]), or TtfA-msfGFP truncations (1-23 [MGM6826], 1-50 [MGM6823], 1-100 [MGM6827], 1-150 [MGM6824], 1-205 [MGM6822], 24-278 [MGM6825]) coexpressing MmpL3-mCherry and probed with anti-RFP (top) and anti-GFP (bottom). (C) The MsTtfA-MmpL3 interaction is independent of mycolate synthesis. GFP-Trap eluates of MmpL3-mCherry expression strains coexpressing msfGFP control (MGM6828) or TtfA-msfGFP with either control CRISPRi (NT [MGM6816]) or Pks13 depleted (MGM6817) for 6 h with ATc. Top panel is probed for MmpL3-mCherry with anti-RFP and bottom with anti-GFP.](https://figures.cochat.ai/paper-figures/6021f9c6db0e45a794f70cf9f2a3fc6f/two-accessory-proteins-govern-mmpl3-mycolic-acid-transport-in-mycobacteria-figure-4.jpg)

![FIG 6 MsTtfA and MtbTtfA are required for TMM transport. (A) Thin-layer chromatographs (TLCs) of extractable mycolic acids from three replicate 14C-acetic acid-labeled M. smegmatis cultures carrying CRISPRi targeting guide RNAs (nontargeting [MGM6418]; left), ttfA (MGM6419; middle), or mmpL3 (MGM6637; right). Isoniazid treatment served as a positive control for inhibition of all mycolate synthesis. (B) Graph of TDM/TMM ratios for quantitation of TMM and TDM of TLCs in panel A. (C) TLCs of extractable mycolic acids from three replicate 14C-acetic acid-labeled M. tuberculosis cultures depleted for TtfA (MGM6675; left) or MmpL3 (MGM6676; right) (D) Quantitation of TDM/TMM ratios from quantitation of TMM and TDM of TLCs in panel C. ***, P < 0.01.](https://figures.cochat.ai/paper-figures/f6ad1bed5e734a8cb43679d69f66c04b/two-accessory-proteins-govern-mmpl3-mycolic-acid-transport-in-mycobacteria-figure-6.jpg)
![FIG 7 MSMEG_5308-msfGFP accumulates in response to MmpL3 dysfunction. (A) Lysates of MSMEG_5308-msfGFP expression strains with CRISPRi constructs nontargeting control (NT [MGM6766]), MmpL3 (MGM6718), TtfA (MGM6717), or Pks13 (MGM6767) (ATc induction at 0, 2, 4, 6, and 8 hrs) and probed with anti-GFP or anti-RpoB. Anti-GFP blot shown between 75 kDa and 63 kDa as determined by molecular weight marker. (B) Lysates of MSMEG_5308-msfGFP expression strain (MGM6681) treated with dimethyl sulfoxide [DMSO], 10 μg/ml INH, 20 μg/ml INH, 5 μM SQ109, 5 μM BM212, or 5 μM AU1235 for 0, 1.5, or 3 hrs and probed with anti-GFP and anti-RpoB (loading control).](https://figures.cochat.ai/paper-figures/89c2dfd74c3c429782d991d82b97902b/two-accessory-proteins-govern-mmpl3-mycolic-acid-transport-in-mycobacteria-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The recent discovery of 2 conserved accessory proteins in M. smegmatis, which stabilize MmpL3, add further insight on the mechanisms of MmpL3 function (157).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [157]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995 · cited 1×
“Excised gel bands were cut into approximately 1-mm3 pieces and subjected to a modified in-gel trypsin digestion procedure as follows (62).”
MethodEng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544 · cited 2×
“Mutational 88 analyses and ‘transposon-site-hybridization’ (TraSH) revealed MmpL3 is essential for 89 Mtb viability in vitro [19] and in vivo [20], and several inhibitors of MmpL3 are already in 90 clinical development, among them are a set of diamine-indole-carboxamides [21-23] 91 including Novartis NITD-304, and the…”
BackgroundinhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 1×
“The enzymatic steps of the arabinogalactan and 66 mycolate precursor biosynthesis have been well described and are the targets of 67 several antimycobacterials, including isoniazid and ethambutol [1-3].”
BackgroundGenetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,354 · cited 1×
“Mutational 88 analyses and ‘transposon-site-hybridization’ (TraSH) revealed MmpL3 is essential for 89 Mtb viability in vitro [19] and in vivo [20], and several inhibitors of MmpL3 are already in 90 clinical development, among them are a set of diamine-indole-carboxamides [21-23] 91 including Novartis NITD-304, and the…”
BackgroundSecretion systems in Gram-negative bacteria: Structural and mechanistic insights
Costa, T. R. D., Felisberto-Rodrigues, C., Meir, A., Prevost, M. S., Redzej, A., Trokter, M., & Waksman, G. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3456 · Cited by 1,132 · cited 1×
“However, AcrB does not act alone: it additionally forms the core of a comprehensive secretion system that traverses both the inner and outer membranes of the cell envelope in Gram-negative bacteria, allowing the AcrB substrates to bypass the periplasm (30).”
Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., & Hughes, C. (2000) · Nature · doi:10.1038/35016007 · Cited by 1,086
Griffin, J. E., Gawronski, J. D., DeJesus, M. A., Ioerger, T. R., Akerley, B. J., & Sassetti, C. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002251 · Cited by 1,048 · cited 1×
“The M. tuberculosis H37Rv homolog of TtfA is Rv0383c. rv0383c was predicted to be an essential gene in H37Rv based on transposon mutagenesis (19, 42), but its essentiality in M. smegmatis and M. tuberculosis is unknown and its molecular function obscure.”
Crystal structure of bacterial multidrug efflux transporter AcrB
Murakami, S., Nakashima, R., Yamashita, E., & Yamaguchi, A. (2002) · Nature · doi:10.1038/nature01050 · Cited by 986 · cited 1×
“To form this 105 membrane spanning system, AcrB interacts with a periplasmic coupling protein called 106 AcrA (or more generally, the Membrane Fusion Protein (MPF)), which in turn links to an 107 outer membrane channel called TolC (or more generally, the Outer Membrane Protein 108 (OMP)) [31-33] The mechanism of bacte…”
BackgroundCrystal structures of a multidrug transporter reveal a functionally rotating mechanism
Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., & Yamaguchi, A. (2006) · Nature · doi:10.1038/nature05076 · Cited by 773 · cited 1×
“To form this 105 membrane spanning system, AcrB interacts with a periplasmic coupling protein called 106 AcrA (or more generally, the Membrane Fusion Protein (MPF)), which in turn links to an 107 outer membrane channel called TolC (or more generally, the Outer Membrane Protein 108 (OMP)) [31-33] The mechanism of bacte…”
BackgroundGlobal landscape of HIV–human protein complexes
Jäger, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L., Li, K., et al. (2012) · Nature · doi:10.1038/nature10719 · Cited by 731 · cited 1×
“Samples were prepared for mass spectrometry analysis as 469 previously described [57].”
MethodSelf-citationStructure of the AcrAB–TolC multidrug efflux pump
Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., Venter, H., Chiu, W., & Luisi, B. F. (2014) · Nature · doi:10.1038/nature13205 · Cited by 662 · cited 1×
“To form this 105 membrane spanning system, AcrB interacts with a periplasmic coupling protein called 106 AcrA (or more generally, the Membrane Fusion Protein (MPF)), which in turn links to an 107 outer membrane channel called TolC (or more generally, the Outer Membrane Protein 108 (OMP)) [31-33] The mechanism of bacte…”
BackgroundGlickman, M. S., Cox, J. S., & Jacobs, W. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80250-6 · Cited by 655 · cited 1×
“tuberculosis these modifications alter 77 host-mycolic acid responses [8-14].”
Self-citationProteomics: the move to mixtures
Peng, J., & Gygi, S. P. (2001) · Journal of Mass Spectrometry · doi:10.1002/jms.229 · Cited by 648 · cited 1×
“6- m C18 spherical silica beads into a fused silica capillary (100- m inner diameter by 30-cm length) with a flame-drawn tip (63).”
Yang, Z. R., Thomson, R., McNeil, P., & Esnouf, R. M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti534 · Cited by 644
Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism
Seeger, M. A., Schiefner, A., Eicher, T., Verrey, F., Diederichs, K., & Pos, K. M. (2006) · Science · doi:10.1126/science.1131542 · Cited by 590 · cited 1×
“To form this 105 membrane spanning system, AcrB interacts with a periplasmic coupling protein called 106 AcrA (or more generally, the Membrane Fusion Protein (MPF)), which in turn links to an 107 outer membrane channel called TolC (or more generally, the Outer Membrane Protein 108 (OMP)) [31-33] The mechanism of bacte…”
BackgroundRock, J. M., Hopkins, F. F., Chavez, A., Diallo, M., Chase, M. R., Gerrick, E. R., Pritchard, J. R., Church, G. M., Rubin, E. J., Sassetti, C. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.274 · Cited by 538
Self-citationTahlan, K., Wilson, R., Kastrinsky, D. B., Arora, K., Nair, V., Fischer, E., Barnes, S. W., Walker, J. R., Alland, D., Barry, C. E., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05708-11 · Cited by 504 · cited 1×
“311 Resistance mutations to SQ109, BM212, and AU1235 arise in MmpL3, however only 312 BM212 and AU1235 have been shown to directly inhibit MmpL3 flippase activity and all 313 three inhibitors may have effects outside of MmpL3 flippase activity [24-26,50].”
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472 · cited 1×
“The enzymatic steps of the arabinogalactan and mycolate precursor biosynthesis have been well described and are the targets of several antimycobacterials, including isoniazid and ethambutol (1–3).”
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Grzegorzewicz, A. E., Pham, H., Gundi, V. A. K. B., Scherman, M. S., North, E. J., Hess, T., Jones, V., Gruppo, V., Born, S. E. M., Korduláková, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.794 · Cited by 442 · cited 3×
“MmpL3 has been shown to have flippase activity in 94 spheroplast assays [25] and genetic depletion leads to growth arrest and loss of TMM 95 transport [26,27].”
BackgroundManganelli, R., Voskuil, M. I., Schoolnik, G. K., & Smith, I. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02525.x · Cited by 421 · cited 2×
“The Rv1057 gene has been shown to be under control of two two152 component systems involved in sensing cell stress, MprAB and TcrRS, as well as the 153 envelope stress responsive sigma factor SigE [38-40].”
Green Fluorescent Protein Functions as a Reporter for Protein Localization in Escherichia coli
Feilmeier, B. J., Iseminger, G., Schroeder, D., Webber, H., & Phillips, G. J. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4068-4076.2000 · Cited by 377 · cited 1×
“It has been previously reported that mCitrine does not fluoresce when 208 localized in the periplasm, suggesting that the C-terminal domain of MsTtfA is localized 209 in the cytoplasmic side of the membrane [45].”
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P., Reed, M. B., & Barry, C. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3492-3501.2005 · Cited by 361 · cited 1×
“MmpL3 is the only MmpL protein that is essential in vitro , though mutations in several other MmpLs severely compromise virulence in infection models (7, 15–18).”
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
Zhang, B., Li, J., Yang, X., Wu, L., Zhang, J., Yang, Y., Zhao, Y., Zhang, L., Yang, X., Yang, X., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.003 · Cited by 263
MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence
Converse, S. E., Mougous, J. D., Leavell, M. D., Leary, J. A., Bertozzi, C. R., & Cox, J. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1030024100 · Cited by 250 · cited 3×
“78 After synthesis, TMM must be transported across the cytoplasmic membrane to 79 reach the cell wall; this step is known to require the MmpL3 transporter [7,15-17].”
BackgroundMethodβ Propellers: structural rigidity and functional diversity
Fülöp, V., & Jones, D. T. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00035-4 · Cited by 231 · cited 1×
“This protein structural motif has been previously described to 372 aid in protein-protein interactions though members are functionally diverse [54-56].”
Tripartite assembly of RND multidrug efflux pumps
Daury, L., Orange, F., Taveau, J.-C., Verchère, A., Monlezun, L., Gounou, C., Marreddy, R. K. R., Picard, M., Broutin, I., Pos, K. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms10731 · Cited by 213 · cited 1×
“To form this 105 membrane spanning system, AcrB interacts with a periplasmic coupling protein called 106 AcrA (or more generally, the Membrane Fusion Protein (MPF)), which in turn links to an 107 outer membrane channel called TolC (or more generally, the Outer Membrane Protein 108 (OMP)) [31-33] The mechanism of bacte…”
BackgroundMmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
La Rosa, V., Poce, G., Canseco, J. O., Buroni, S., Pasca, M. R., Biava, M., Raju, R. M., Porretta, G. C., Alfonso, S., Battilocchio, C., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05270-11 · Cited by 212 · cited 5×
“We further examined the response of MSMEG_5308 to inhibitors of the TMM/TDM pathway, including early mycolate biosynthesis (isoniazid [INH]) and inhibitors targeting late steps in TMM/TDM transport (SQ109, BM212, and AU1235).”
InfluentialMmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
Varela, C., Rittmann, D., Singh, A., Krumbach, K., Bhatt, K., Eggeling, L., Besra, G. S., & Bhatt, A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.03.006 · Cited by 210 · cited 2×
“MmpL3 has been shown to have flippase activity in 94 spheroplast assays [25] and genetic depletion leads to growth arrest and loss of TMM 95 transport [26,27].”
BackgroundMmpL3 is the flippase for mycolic acids in mycobacteria
Xu, Z., Meshcheryakov, V. A., Poce, G., & Chng, S.-S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700062114 · Cited by 201 · cited 3×
“MmpL3 has been shown to have flippase activity in 94 spheroplast assays [25] and genetic depletion leads to growth arrest and loss of TMM 95 transport [26,27].”
BackgroundRao, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27335 · Cited by 200 · cited 1×
“tuberculosis these modifications alter 77 host-mycolic acid responses [8-14].”
Crystal Structures of Mycolic Acid Cyclopropane Synthases from Mycobacterium tuberculosis
Huang, C.-C., Smith, C. V., Glickman, M. S., Jacobs, W. R., & Sacchettini, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111698200 · Cited by 191
Self-citationThe many blades of the β-propeller proteins: conserved but versatile
Chen, C. K.-M., Chan, N.-L., & Wang, A. H.-J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.004 · Cited by 188
Stec, J., Onajole, O. K., Lun, S., Guo, H., Merenbloom, B., Vistoli, G., Bishai, W. R., & Kozikowski, A. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00415 · Cited by 170 · cited 1×
“…hybridization” (TraSH) revealed MmpL3 is essential for M. tuberculosis viability in vitro (19) and in vivo (20), and several inhibitors of MmpL3 are already in clinical development, among them are a set of diamine-indole-carboxamides (21–23), including Novartis NITD-304 and the pyrrole BM212 (24).”
The Role of MmpL8 in Sulfatide Biogenesis and Virulence of Mycobacterium tuberculosis
Domenech, P., Reed, M. B., Dowd, C. S., Manca, C., Kaplan, G., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400324200 · Cited by 163 · cited 1×
“For example, deletion of the sulfolipid transporter MmpL8 361 abolishes sulfolipid synthesis, rather than simply inhibiting its transport [16,51].”
The Arabinosyltransferase EmbC Is Inhibited by Ethambutol in Mycobacterium tuberculosis
Goude, R., Amin, A. G., Chatterjee, D., & Parish, T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00162-09 · Cited by 157 · cited 1×
“The enzymatic steps of the arabinogalactan and 66 mycolate precursor biosynthesis have been well described and are the targets of 67 several antimycobacterials, including isoniazid and ethambutol [1-3].”
Indoleamides are active against drug-resistant Mycobacterium tuberculosis
Lun, S., Guo, H., Onajole, O. K., Pieroni, M., Gunosewoyo, H., Chen, G., Tipparaju, S. K., Ammerman, N. C., Kozikowski, A. P., & Bishai, W. R. (2013) · Nature Communications · doi:10.1038/ncomms3907 · Cited by 150
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Rao, S. P. S., Lakshminarayana, S. B., Kondreddi, R. R., Herve, M., Camacho, L. R., Bifani, P., Kalapala, S. K., Jiricek, J., Ma, N. L., Tan, B. H., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007355 · Cited by 147 · cited 1×
“…hybridization” (TraSH) revealed MmpL3 is essential for M. tuberculosis viability in vitro (19) and in vivo (20), and several inhibitors of MmpL3 are already in clinical development, among them are a set of diamine-indole-carboxamides (21–23), including Novartis NITD-304 and the pyrrole BM212 (24).”
The Mycobacterium tuberculosis cmaA2 Gene Encodes a Mycolic Acid trans-Cyclopropane Synthetase
Glickman, M. S., Cahill, S. M., & Jacobs, W. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000652200 · Cited by 136 · cited 1×
“tuberculosis these modifications alter 77 host-mycolic acid responses [8-14].”
Self-citationEvolution of the β‐propeller fold
Chaudhuri, I., Söding, J., & Lupas, A. N. (2008) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21764 · Cited by 135
The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis
Gavalda, S., Léger, M., van der Rest, B., Stella, A., Bardou, F., Montrozier, H., Chalut, C., Burlet-Schiltz, O., Marrakchi, H., Daffé, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006940 · Cited by 134
Viljoen, A., Dubois, V., Girard‐Misguich, F., Blaise, M., Herrmann, J., & Kremer, L. (2017) · Molecular Microbiology · doi:10.1111/mmi.13675 · Cited by 134 · cited 1×
“Like AcrB, the MmpLs are thought to be localized to the inner membrane (29).”
The Polyketide Synthase Pks13 Catalyzes a Novel Mechanism of Lipid Transfer in Mycobacteria
Gavalda, S., Bardou, F., Laval, F., Bon, C., Malaga, W., Chalut, C., Guilhot, C., Mourey, L., Daffé, M., & Quémard, A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.10.011 · Cited by 129 · cited 1×
“71 Pks13 catalyzes the final condensation step to produce α-alkyl β-ketoacids (C60-C90) 72 which are then acetylated and transferred to the 6 position of trehalose [4,5].”
BackgroundBernut, A., Viljoen, A., Dupont, C., Sapriel, G., Blaise, M., Bouchier, C., Brosch, R., de Chastellier, C., Herrmann, J., & Kremer, L. (2016) · Molecular Microbiology · doi:10.1111/mmi.13283 · Cited by 127
Jain, M., & Cox, J. S. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010002 · Cited by 125 · cited 1×
“362 Similarly, MmpL7 is physically and functionally coupled to PDIM biosynthesis [52].”
BackgroundBarkan, D., Liu, Z., Sacchettini, J. C., & Glickman, M. S. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.04.001 · Cited by 125 · cited 1×
“tuberculosis these modifications alter 77 host-mycolic acid responses [8-14].”
BackgroundSelf-citationPacheco, S. A., Hsu, F.-F., Powers, K. M., & Purdy, G. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.473371 · Cited by 123 · cited 3×
“78 After synthesis, TMM must be transported across the cytoplasmic membrane to 79 reach the cell wall; this step is known to require the MmpL3 transporter [7,15-17].”
Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis
Rath, P., Huang, C., Wang, T., Wang, T., Li, H., Prados‐Rosales, R., Elemento, O., Casadevall, A., & Nathan, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320118110 · Cited by 122 · cited 1×
“369 tuberculosis, that we also find in our purifications of MsTtfA [53].”
BackgroundEssentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
Degiacomi, G., Benjak, A., Madacki, J., Boldrin, F., Provvedi, R., Palù, G., Kordulakova, J., Cole, S. T., & Manganelli, R. (2017) · Scientific Reports · doi:10.1038/srep43495 · Cited by 111 · cited 1×
“Rv1057 was also reported to be 154 the most transcriptionally induced gene in response to MmpL3 depletion [41], 155 suggesting a connection to MmpL3 function.”
BackgroundLea-Smith, D. J., Pyke, J. S., Tull, D., McConville, M. J., Coppel, R. L., & Crellin, P. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608686200 · Cited by 100 · cited 1×
“Mono- -alkyl -ketoacyl trehalose is then reduced by CmrA to trehalose monomycolate (TMM) presumably in the inner leaflet of the cytoplasmic membrane (6, 65).”
The Dual Function of the Mycobacterium tuberculosis FadD32 Required for Mycolic Acid Biosynthesis
Léger, M., Gavalda, S., Guillet, V., van der Rest, B., Slama, N., Montrozier, H. L., Mourey, L., Quémard, A., Daffé, M., & Marrakchi, H. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.03.012 · Cited by 97
An Essential Nonredundant Role for Mycobacterial DnaK in Native Protein Folding
Fay, A., & Glickman, M. S. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004516 · Cited by 96 · cited 2×
“As a control for essential protein 290 depletion, we depleted the essential DnaK chaperone [43] and found no effect on 14C291 TMM/14C-TDM, indicating that cell arrest by depletion of any essential protein does not 292 alter TMM and TDM levels (Fig S4).”
MethodSelf-citationCarel, C., Nukdee, K., Cantaloube, S., Bonne, M., Diagne, C. T., Laval, F., Daffé, M., & Zerbib, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097148 · Cited by 89 · cited 3×
“All three of these 347 proteins localize to cell poles and septa, which are the sites of cell elongation and the 348 previously reported localization sites of early mycolic acid synthetic machinery such as 349 MabA and InhA [49].”
BackgroundInfluentialGlickman, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212458200 · Cited by 89
Self-citationBarkan, D., Hedhli, D., Yan, H.-G., Huygen, K., & Glickman, M. S. (2012) · Infection and Immunity · doi:10.1128/iai.00021-12 · Cited by 83
Self-citationBiosynthesis and Translocation of Unsulfated Acyltrehaloses in Mycobacterium tuberculosis
Belardinelli, J. M., Larrouy-Maumus, G., Jones, V., Sorio de Carvalho, L. P., McNeil, M. R., & Jackson, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581199 · Cited by 79
Burbaud, S., Laval, F., Lemassu, A., Daffé, M., Guilhot, C., & Chalut, C. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.11.013 · Cited by 68 · cited 1×
“Additionally, loss of MmpL10 abolishes synthesis of polyacyl-trehaloses and trehalose polyphleates (53–55).”
Bergeret, F., Gavalda, S., Chalut, C., Malaga, W., Quémard, A., Pédelacq, J. D., Daffé, M., Guilhot, C., Mourey, L., & Bon, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325639 · Cited by 50 · cited 1×
“71 Pks13 catalyzes the final condensation step to produce α-alkyl β-ketoacids (C60-C90) 72 which are then acetylated and transferred to the 6 position of trehalose [4,5].”
Bhatt, A., Brown, A. K., Singh, A., Minnikin, D. E., & Besra, G. S. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.07.007 · Cited by 48
Haydel, S. E., & Clark‐Curtiss, J. E. (2005) · Journal of Bacteriology · doi:10.1128/jb.188.1.150-159.2006 · Cited by 44 · cited 1×
“tuberculosis, the MSMEG_5308 homolog, Rv1057, is responsive to a variety of membrane stresses as well as MmpL3 depletion (38, 39, 41).”
Mechanistic insight into mycobacterial MmpL protein function
Székely, R., & Cole, S. T. (2015) · Molecular Microbiology · doi:10.1111/mmi.13306 · Cited by 37 · cited 1×
“MmpL3 is the only MmpL protein that is essential in vitro , though mutations in several other MmpLs severely compromise virulence in infection models (7, 15–18).”
Touchette, M. H., Holsclaw, C. M., Previti, M. L., Solomon, V. C., Leary, J. A., Bertozzi, C. R., & Seeliger, J. C. (2015) · Journal of Bacteriology · doi:10.1128/jb.02015-14 · Cited by 28 · cited 1×
“Additionally, loss of MmpL10 abolishes synthesis of polyacyl-trehaloses and trehalose polyphleates (53–55).”
Pang, X., Cao, G., Neuenschwander, P. F., Haydel, S. E., Hou, G., & Howard, S. T. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.10.024 · Cited by 27
Fu, J., Zong, G., Zhang, P., Gu, Y., & Cao, G. (2017) · Current Microbiology · doi:10.1007/s00284-017-1394-8 · Cited by 13
Cited by
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research
Sparks, I. L., Derbyshire, K. M., Jacobs, W. R., & Morita, Y. S. (2023) · Journal of Bacteriology · doi:10.1128/jb.00337-22 · Cited by 149
“smegmatis, which stabilize MmpL3, add further insight on the mechanisms of MmpL3 function (157).”
BackgroundStructural and Functional Diversity of Resistance–Nodulation–Cell Division Transporters
Klenotic, P. A., Moseng, M. A., Morgan, C. E., & Yu, E. W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00621 · Cited by 111
Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope
Jackson, M., Stevens, C. M., Zhang, L., Zgurskaya, H. I., & Niederweis, M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00869 · Cited by 77
Synthesis and recycling of the mycobacterial cell envelope
Abrahams, K. A., & Besra, G. S. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.01.012 · Cited by 55
Belardinelli, J. M., Stevens, C. M., Li, W., Tan, Y. Z., Jones, V., Mancia, F., Zgurskaya, H. I., & Jackson, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47159-8 · Cited by 54
Metadata
- Authors
- Fay, A., Czudnochowski, N., Rock, J. M., Johnson, J. R., Krogan, N. J., Rosenberg, O., & Glickman, M. S.
- Affiliations
- Immunology Program, Sloan Kettering Institute, New York, New York, USA
- University of California, San Francisco (US)
- Rockefeller University (US)
- Gladstone Institutes (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Glickman, Michael S.
- ORCID
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2019-06-25
- Volume
- 10
- Issue
- 3
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC6593404
- OpenAlex
- W2954810968
- Cited by
- 65
- References
- 65
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 11 · 2022: 3 · 2021: 8 · 2020: 10 · 2019: 5
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- HHS | NIH | National Cancer Institute (P30 CA008748)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (U19-111143, R01 AI120694, P01 AI063302, 1U19AI135990, 5R01AI128214, P01AI095208)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- Mycobacterium tuberculosis, accessory proteins, cell envelope biosynthesis, mycobacterial cell wall, protein complex stabilization, cell viability
- MeSH terms
- Bacterial Proteins, Cell Membrane, Cell Wall, Mycobacterium tuberculosis, Mycolic Acids, Mycobacterium smegmatis, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.